Phenolic-derived compounds in osteoporosis—Mechanisms, clinical evidence, and drug delivery: A review
Haryati Ahmad Hairi, Rusdiah Ruzanna Jusoh, Muhammad Zulfiqah Sadikan, Ahmad Nazrun Shuid · 2026
Read Phenolic-derived compounds in osteoporosis—Mechanisms, clinical evidence, and drug delivery: A review by Haryati Ahmad Hairi, Rusdiah Ruzanna Jusoh, Muhammad Zulfiqah Sadikan, Ahmad Nazrun Shuid (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13130750.txt.
Description
Haryati Ahmad Hairi and colleagues reviewed plant phenolic compounds as a possible aid against osteoporosis. Osteoporosis thins bone and weakens its structure, raising fracture risk. It develops when bone removal outruns bone building, driven by oxidative stress, long-term inflammation, cell-death pathways, and hormone change, especially loss of estrogen.
Sections explain those disease mechanisms first, with stress and hormone problems given special weight. Evidence on phenolic compounds follows, including recent clinical observations and delivery methods meant to make the compounds work better. The authors judge these plant-based compounds promising for preventing and managing weak bones, while presenting them as a strategy still being developed.
Catalog record
| CREATOR | Haryati Ahmad Hairi, Rusdiah Ruzanna Jusoh, Muhammad Zulfiqah Sadikan, Ahmad Nazrun Shuid |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |